Hayasaka et al. examined the effect of CXCL12 on the CCR7-dependent signaling in MDA-MB-231 human BC cells and found that CXCL12 promotes homodimer formation, ligand binding, and cellular responses at lower concentrations of CCL19 [29]. Here, CXCL12 is linked to breast cancer.